Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Despite tariffs, the US imported a record number of panels through November of last year.
An insurance nonprofit found that claims about autonomous driving safety don’t measure up.
Southwest and Alaska said that the manufacturer’s uncertain status makes it hard to forecast the year ahead.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Bioprospecting for genes of new species in the world’s oceans has become complex and extremely lucrative.
Temu is now one of the biggest ad clients for both Google and Meta, according to The Wall Street Journal and The New York Times.
Novo Nordisk has announced a new drug in its pipeline performed much better than Wegovy in helping participants to lose weight.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
The retailer is looking to spark its turnaround with its own version of an e-commerce membership.
Demand for nuclear power has jumped as many countries are increasingly intent on leaving fossil fuels behind.
An auto tech patent from Apple highlights that the iPhone maker has tons of vehicle-related intellectual property – and nowhere to use it.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.